Water Quality in BELEN, NM (87002)
EPA violation data for public water systems serving ZIP code 87002.
364
Total Violations
69
Health-Based
295
Monitoring / Reporting
359
Resolved
What does this mean?
359 of 364 violations have been resolved. 69 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 295 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Water systems: 24 Population served: 12,950
Violations Detail (364 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 5, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 5, 2025 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 7, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 7, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 7, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Feb 20, 2025 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.026 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.026 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Dec 19, 2024 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Nov 22, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 22, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 22, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Nov 7, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.03 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.03 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | May 3, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 3, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.02 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.019 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.019 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 7, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 18, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 29, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| E. COLI | Monitoring | 0 | N/A | Sep 17, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 17, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 17, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 17, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 16, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 16, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 16, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 4, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 8, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 23, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 19, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.018 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 1, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 11, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 5, 2021 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Jul 24, 2021 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Jul 24, 2021 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Jul 24, 2021 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Jul 24, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jun 23, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 18, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(6)
Revised Total Coliform Rule
2A
Apr 5Active
Revised Total Coliform Rule
2A
Apr 5Active
E. COLI
34
Mar 7Resolved
E. COLI
34
Mar 7Resolved
E. COLI
34
Mar 7Resolved
Public Notice
75
Feb 20Active
2024(36)
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Public Notice
75
Dec 19Active
E. COLI
34
Nov 22Resolved
E. COLI
34
Nov 22Resolved
E. COLI
34
Nov 22Resolved
Public Notice
75
Nov 7Active
LEAD AND COPPER RULE REVISIONS
4G
Oct 16Resolved
LEAD AND COPPER RULE REVISIONS
4G
Oct 16Resolved
LEAD AND COPPER RULE REVISIONS
4G
Oct 16Resolved
LEAD AND COPPER RULE REVISIONS
2E
Oct 16Resolved
LEAD AND COPPER RULE REVISIONS
2E
Oct 16Resolved
LEAD AND COPPER RULE REVISIONS
2E
Oct 16Resolved
LEAD AND COPPER RULE REVISIONS
2E
Oct 16Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Public Notice
75
May 3Resolved
Public Notice
75
May 3Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
2023(62)
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Chlorine
27
Sep 30Resolved
Chlorine
27
Sep 30Resolved
Chlorine
27
Sep 30Resolved
Chlorine
27
Sep 30Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Chlorine
27
Jun 30Resolved
Chlorine
27
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Chlorine
27
Jun 30Resolved
Chlorine
27
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Public Notice
75
Apr 7Resolved
Public Notice
75
Apr 7Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Public Notice
75
Mar 18Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
2022(81)
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Public Notice
75
Dec 29Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
E. COLI
34
Sep 17Resolved
E. COLI
34
Sep 17Resolved
E. COLI
34
Sep 17Resolved
E. COLI
34
Sep 17Resolved
Total Haloacetic Acids (HAA5)
27
Jul 31Resolved
Total Haloacetic Acids (HAA5)
27
Jul 31Resolved
TTHM
27
Jul 31Resolved
TTHM
27
Jul 31Resolved
TTHM
27
Jul 31Resolved
TTHM
27
Jul 31Resolved
Total Haloacetic Acids (HAA5)
27
Jul 31Resolved
Total Haloacetic Acids (HAA5)
27
Jul 31Resolved
Arsenic
02
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Lead and Copper Rule
52
Jun 30Resolved
Lead and Copper Rule
52
Jun 30Resolved
Lead and Copper Rule
52
Jun 30Resolved
Lead and Copper Rule
52
Jun 30Resolved
Public Notice
75
Jun 16Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Public Notice
75
Apr 16Resolved
Public Notice
75
Apr 16Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Public Notice
75
Mar 4Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
2021(179)
Chlorine
27
Dec 31Resolved
Chlorine
27
Dec 31Resolved
Chlorine
27
Dec 31Resolved
Chlorine
27
Dec 31Resolved
Chlorine
27
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Chlorine
27
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Arsenic
03
Dec 31Resolved
Chlorine
27
Dec 31Resolved
Chlorine
27
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Public Notice
75
Dec 8Resolved
Public Notice
75
Nov 18Resolved
Public Notice
75
Oct 23Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Groundwater Rule
45
Oct 19Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Chlorine
27
Sep 30Resolved
Chlorine
27
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Chlorine
27
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Chlorine
27
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Lead and Copper Rule
52
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Lead and Copper Rule
52
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Lead and Copper Rule
52
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 30Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 29Resolved
Public Notice
75
Sep 1Resolved
Public Notice
75
Aug 11Resolved
Public Notice
75
Aug 5Resolved
Groundwater Rule
20
Jul 24Resolved
Groundwater Rule
20
Jul 24Resolved
Groundwater Rule
20
Jul 24Resolved
Groundwater Rule
20
Jul 24Resolved
Arsenic
03
Jun 30Resolved
E. COLI
34
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
E. COLI
34
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
E. COLI
34
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
03
Jun 30Resolved
E. COLI
34
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Public Notice
75
Jun 23Resolved
Arsenic
03
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Public Notice
75
Mar 18Resolved
Public Notice
75
Mar 18Resolved
Public Notice
75
Mar 18Resolved
Public Notice
75
Mar 18Resolved
Public Notice
75
Mar 18Resolved
Public Notice
75
Mar 18Resolved
Public Notice
75
Mar 18Resolved
Public Notice
75
Feb 18Resolved
How Does This Compare?
BELEN (87002) has 364 recorded violations, including 69 health-based. 5 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
Activated Carbon Filter
Excellent for removing chlorine, chloramine, and disinfection byproducts like THMs and HAAs. Available as pitcher filters, countertop, or under-sink units.
Targets:THMs, HAAs, Chlorine, Chloramine, Taste & Odor
Look for:NSF/ANSI 42 & 53 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.